Fougera’s clotrimazole approved by FDA
MELVILLE, N.Y. The Food and Drug Administration has approved Fougera division Nycomed US’s clotrimazole cream USP, Nycomed announced Friday.
The cream, available in a 1 percent formulation, is available in 15 g, 30 g and 45 g tubes. It is approved for treating yeast infections.
“The approval of clotrimazole cream is another illustration of Fougera’s robust product pipeline,” Fougera senior vice president and general manager David Klaum said. “With each product approval, Fougera reaffirms its commitment to providing safe, effective and affordable options to healthcare providers and their patients.”
UI sues Amgen over patent infringement
IOWA CITY, Iowa A major biotech company has trouble with the University of Iowa.
The university is suing Amgen, alleging that it has knowingly infringed on its patents for several years, specifically in its manufacture of drugs such as the rheumatoid arthritis and psoriasis treatment Enbrel (etanercept).
The university is demanding unspecified damages from the Thousand Oaks, Calif., company.
Take Care adds four new vaccines to its program
CONSHOHOCKEN, Pa. Take Care Health Systems, which is owned by Walgreens, has expanded its vaccine program with four new vaccines.
The new vaccination suite includes varicella (chickenpox); measles, mumps and rubella (MMR); pneumococcal (PPV); and human pappilomavirus (HPV).
These vaccinations—in addition to hepatitis B, menactra (meningitis), shingles, tetanus, diphtheria, pertussis (Tdap) and tetanus booster (Td)—are now available at all 223 Take Care clinics within Walgreens.
Flu shots will also be available from Oct. 1 through early 2009.
“Vaccinations are the cornerstone of disease prevention and health promotion,” stated Sandy Ryan, chief nurse practitioner officer at Take Care Health Systems. “Routine immunizations are critical for both children and adults. Adults should ensure they are up to date on recommended vaccines to prevent against common, yet serious, diseases.”